404 related articles for article (PubMed ID: 32460357)
1. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.
Tan M; Liu Y; Zhou R; Deng X; Li F; Liang K; Shi Y
Immunology; 2020 Jul; 160(3):261-268. PubMed ID: 32460357
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
4. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
5. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological features of severe and moderate coronavirus disease 2019.
Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
[TBL] [Abstract][Full Text] [Related]
7. Long-term infection of SARS-CoV-2 changed the body's immune status.
Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
[TBL] [Abstract][Full Text] [Related]
8. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
9. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients.
Liu B; Han J; Cheng X; Yu L; Zhang L; Wang W; Ni L; Wei C; Huang Y; Cheng Z
Sci Rep; 2020 Oct; 10(1):17718. PubMed ID: 33077873
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 pneumonia: CD8
Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
[TBL] [Abstract][Full Text] [Related]
11. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
Mazzoni A; Salvati L; Maggi L; Capone M; Vanni A; Spinicci M; Mencarini J; Caporale R; Peruzzi B; Antonelli A; Trotta M; Zammarchi L; Ciani L; Gori L; Lazzeri C; Matucci A; Vultaggio A; Rossi O; Almerigogna F; Parronchi P; Fontanari P; Lavorini F; Peris A; Rossolini GM; Bartoloni A; Romagnani S; Liotta F; Annunziato F; Cosmi L
J Clin Invest; 2020 Sep; 130(9):4694-4703. PubMed ID: 32463803
[TBL] [Abstract][Full Text] [Related]
12. Immune dysfunction following COVID-19, especially in severe patients.
Song CY; Xu J; He JQ; Lu YQ
Sci Rep; 2020 Sep; 10(1):15838. PubMed ID: 32985562
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological investigation of patients with severe COVID-19.
Li S; Jiang L; Li X; Lin F; Wang Y; Li B; Jiang T; An W; Liu S; Liu H; Xu P; Zhao L; Zhang L; Mu J; Wang H; Kang J; Li Y; Huang L; Zhu C; Zhao S; Lu J; Ji J; Zhao J
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427582
[TBL] [Abstract][Full Text] [Related]
14. Lymphopenia in COVID-19: Therapeutic opportunities.
Fathi N; Rezaei N
Cell Biol Int; 2020 Sep; 44(9):1792-1797. PubMed ID: 32458561
[TBL] [Abstract][Full Text] [Related]
15. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
Song JW; Zhang C; Fan X; Meng FP; Xu Z; Xia P; Cao WJ; Yang T; Dai XP; Wang SY; Xu RN; Jiang TJ; Li WG; Zhang DW; Zhao P; Shi M; Agrati C; Ippolito G; Maeurer M; Zumla A; Wang FS; Zhang JY
Nat Commun; 2020 Jul; 11(1):3410. PubMed ID: 32641700
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Cell Infiltration of Adrenals in COVID-19.
Zinserling VA; Semenova NY; Markov AG; Rybalchenko OV; Wang J; Rodionov RN; Bornstein SR
Horm Metab Res; 2020 Sep; 52(9):639-641. PubMed ID: 32629518
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
18. Resistance of children to Covid-19. How?
Fischer A
Mucosal Immunol; 2020 Jul; 13(4):563-565. PubMed ID: 32467603
[No Abstract] [Full Text] [Related]
19. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
